Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | STAT3 |
| Upstream (Parents) |
|---|
| (<<) TFAP2A → STAT3 |
| (<<) RCAN1 → STAT3 |
| (<<) TP53 → STAT3 |
| (<<) MAF → STAT3 |
| (<<) ZFP36L2 → STAT3 |
| (<<) JUND → STAT3 |
| (<<) SP1 → STAT3 |
| (<<) TEAD2 → STAT3 |
| (<<) NFYC → STAT3 |
| (<<) HMGB1 → STAT3 |
| (<<) ATF2 → STAT3 |
| Downstream (Children) |
|---|
| STAT3 → MYCN (>>) |
| STAT3 → WT1 (>>) |
| STAT3 → CTBP1 (>>) |
| STAT3 → PAX7 (>>) |
| STAT3 → TFAP2C (>>) |
| STAT3 → TFDP2 (>>) |
| STAT3 → HES6 (>>) |
| STAT3 → CSDA (>>) |
| STAT3 → FOXO3 (>>) |
| STAT3 → ZHX1 (>>) |
| STAT3 → TCF3 (>>) |
| STAT3 → ATF7 (>>) |
| STAT3 → TEAD1 (>>) |
| STAT3 → JUN (>>) |
| STAT3 → STRN3 (>>) |
| STAT3 → GATAD2A (>>) |
